23andMe Appears in 97.0% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
10 minutes read

Key Takeaways

  • 23andMe has very high mention coverage, but AI recommendations are much lower than its mention rate.
  • The main issue is not awareness; it is earning stronger endorsement and top-ranked placement in answers.
  • Several conflicting claims about business status, FDA authorization, and pricing need primary-source verification.
  • Priority work focuses on the company’s own accuracy and ancestry pages, plus the most-cited external review pages.

Answer Capsule

In November 2026, 23andMe appeared in 544 of 561 AI answers included in the DNA Testing Kits benchmark (96.97%). It received 275 recommendations (49.02%), with 213 Top 3 placements and 5 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do 23andMe mentions, recommendations and placements compare with its DNA Testing Kits peers?

23andMe recorded 544 mentions (96.97%) and 275 recommendations (49.02%) across 561 answers included in the benchmark. Top 3 placements numbered 213; first-place recommendations numbered 5. Framing among its mentions was 296 positive, 239 neutral and 9 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

AncestryDNA

560

99.82%

349

62.21%

317

56.51%

305

54.37%

2

23andMe

544

96.97%

275

49.02%

213

37.97%

5

0.89%

3

MyHeritage DNA

442

78.79%

243

43.32%

177

31.55%

9

1.60%

4

FamilyTreeDNA

388

69.16%

205

36.54%

100

17.83%

3

0.53%

5

Nebula Genomics

154

27.45%

95

16.93%

30

5.35%

3

0.53%

6

Living DNA

183

32.62%

73

13.01%

9

1.60%

1

0.18%

7

tellmeGen

22

3.92%

7

1.25%

3

0.53%

1

0.18%

8

African Ancestry

30

5.35%

4

0.71%

3

0.53%

1

0.18%

8

CRI Genetics

17

3.03%

4

0.71%

0

0.00%

0

0.00%

10

Health Nucleus

0

0.00%

0

0.00%

0

0.00%

0

0.00%

23andMe is named in almost every answer, so reach is not the constraint. The gap sits between being mentioned and being put forward: recommendations appear in roughly half of answers, and first-place placement is rare. That pattern suggests the brand is treated as a familiar reference point rather than a default pick.

Framing is mostly positive or neutral, with few negative mentions, so tone is not the main problem either. The practical implication is that the client's opportunity lies in earning affirmative endorsement and stronger positioning, not in raising awareness. We would build a scorecard that tracks reach, recommendation and position as separate measures so progress is judged honestly.

What changed since last month

Questions This Section Answers

  • How did 23andMe counts and coverage differ across the available monthly snapshots?

Metric

Jul 2026

Aug 2026

Sep 2026

Oct 2026

Nov 2026

Mentions

582 / 594 (97.98%)

584 / 607 (96.21%)

587 / 614 (95.60%)

547 / 563 (97.16%)

544 / 561 (96.97%)

Recommendations

422 / 594 (71.04%)

405 / 607 (66.72%)

400 / 614 (65.15%)

379 / 563 (67.32%)

275 / 561 (49.02%)

Top 3 recommendations

401 / 594 (67.51%)

363 / 607 (59.80%)

357 / 614 (58.14%)

347 / 563 (61.63%)

213 / 561 (37.97%)

#1 recommendations

18 / 594 (3.03%)

9 / 607 (1.48%)

8 / 614 (1.30%)

9 / 563 (1.60%)

5 / 561 (0.89%)

From October 2026 to November 2026, 23andMe's mention count fell from 547 to 544, while its recommendation count fell from 379 to 275. The recommendation rate was 67.32% and 49.02% respectively.

The monthly record shows a clear drop in recommendations and top-three placements between the two most recent samples, while mentions held close to their earlier level. First-place placements also eased. These are separate selected samples, so the movement describes what was recorded rather than a proven trend.

Because the answer sets differ between months, the change in counts cannot be attributed to any single cause, and the smaller sample does not explain the rate movement. We would treat the latest month as a fresh baseline and watch the next samples before drawing conclusions, while flagging the recommendation gap as the area to investigate.

AI recommendation trend

Observed recommendation rate (%), Jul 2026 to Nov 2026

0%20%40%60%80%Jul 2026Aug 2026Sep 2026Oct 2026Nov 202671.04%Jul 2026: 71.04%66.72%Aug 2026: 66.72%65.15%Sep 2026: 65.15%67.32%Oct 2026: 67.32%49.02%Nov 2026: 49.02%
  • 23andMe49.02%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for 23andMe?

AI answers contained 41 conflicting claims about 23andMe: 17 critical, 11 high, 13 medium, 0 low. Of these, 28 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

The fact-check list gives the client a way to separate reputation risk from noise. Dozens of conflicting claims were recorded, and a large share were rated critical or high priority, which is enough to justify a structured review rather than ad hoc responses. The ratings order the work; they do not prove anyone made a mistake.

We would pair that list with the visibility comparison so the client can see which disputed topics sit alongside the weakest recommendation performance. The output is a prioritized register with an owner and an evidence requirement for each item, so effort goes to the claims most likely to shape buyer perception.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about 23andMe should be verified before proposed page edits?

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

is it still in business

high

available / recommended as a current option

filed for bankruptcy in 2025

FDA authorization for health reports

medium

only FDA-authorized consumer kit for genetic health risk reports

uses FDA-authorized genotyping chips (not stated as exclusive)

FDA authorization for health reports

medium

FDA-authorized but not exclusive

only FDA-authorized consumer kit

Health + Ancestry kit price

medium

$150-$300

$312.99

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The disputed topics cluster around whether the company is still operating, how its health reporting is authorized, and what the kit costs. Each is the kind of question a cautious buyer asks before purchasing, so unresolved conflicts carry commercial weight even when the underlying facts are mundane.

We would not decide which recorded claim is correct. Instead, the client confirms current facts from primary sources, including dates and product versions, and we draft conditional page briefs that can be published once those facts are approved. Where the entity or timing is ambiguous, the item stays out of the correction queue.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for 23andMe?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://yahoo.com/lifestyle/articles/best-dna-test-2025-035100700.html

12

10

17

https://yourdnaguide.com/ydgblog/best-dna-tests-ancestry

206

144

15

https://nytimes.com/wirecutter/reviews/best-dna-test/

136

110

15

https://guidetogenetics.com/best-dna-tests-overall/

28

23

15

https://forbes.com/health/medical-supplies/best-dna-testing-kit/

23

15

15

https://dnaweekly.com/

155

113

14

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

Several widely cited review pages are linked to multiple conflicting claims, and a few of them appear far more often than the rest. That makes them sensible starting points for source review, but citation alone does not show that a page shaped an answer, and a linked conflict is not proof of publisher error.

We would check the current contents of the shortlisted pages, then prepare evidence-backed requests only where a genuine inaccuracy is confirmed. Requests would be framed around specific, verifiable facts, with a clear record of what was asked, what changed and what did not.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed 23andMe website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://customercare.23andme.com/hc/en-us/articles/360044957274-How-Accurate-Is-23andMe

16

12

12

https://23andme.com/

11

10

4

https://customercare.23andme.com/hc/en-us/articles/115004349807-Understanding-Your-Ancestry-Composition-Results

10

7

5

https://customercare.23andme.com/hc/en-us/articles/212169298-23andMe-Reference-Populations-Regions

8

5

5

https://customercare.23andme.com/hc/en-us/articles/115013846688-What-Ancestry-Information-Can-I-Learn-from-23andMe

6

3

2

https://customercare.23andme.com/hc/en-us/articles/360003184973-Country-Matches-and-Genetic-Groups

4

2

2

https://customercare.23andme.com/hc/en-us/articles/115013698107-About-the-23andMe-Ancestry-Service

3

2

2

https://customercare.23andme.com/hc/en-us/articles/5328923468183-Understanding-The-Difference-Between-Your-Ancestry-Percentages-Your-Country-Matches-and-Your-Genetic-Groups

3

1

1

The company's website was cited 82 times across 27 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The company's own pages are cited across many answers, and the accuracy and ancestry-explanation articles carry the most weight. That gives the client real leverage: clearer, well-sourced explanations on those pages can support the questions buyers actually ask, without relying on third parties.

We would prepare page briefs for the selected articles using approved facts and plain audience questions, starting with the accuracy page and the main site entry point. Each brief would note what the page should answer and which claims need sign-off, and existing coverage would be checked before any new page is proposed.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for 23andMe?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What is the most accurate DNA test kit?

6

6

6

What is the most accurate DNA test to take?

6

6

6

What is the best DNA at-home test?

5

5

5

What is the best company to get a DNA test from?

5

5

5

Which DNA kit is most accurate?

5

5

5

Which DNA test is the most accurate for Ancestry?

5

5

5

Which DNA company is most accurate?

6

6

4

What DNA test tells your heritage?

5

5

4

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions are tightly focused on accuracy and on which company or kit to choose, and 23andMe appears in nearly all of them. That is a useful signal about the shape of buyer interest, though it is not search volume or proof that the website lacks content.

We would turn these into content briefs that answer the accuracy question directly and explain how ancestry results should be read, checking existing pages first. The aim is content that gives an AI answer a clear, citable reason to recommend the brand rather than merely name it.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed 23andMe work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first month establishes the baseline scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and review status. The second month produces approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses recorded separately.

The final month delivers buyer-content briefs and a fresh scorecard. Throughout, completed work is reported apart from measured answer outcomes, and comparability limits are stated alongside any month-to-month reading. No visibility gain is promised; the plan is designed to make progress visible and verifiable.

Methodology

Questions This Section Answers

  • How are 23andMe answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 561 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5891 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Jul 2026

594

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Aug 2026

607

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Sep 2026

614

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Oct 2026

563

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Nov 2026

561

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

The report covers a single month, and the exact collection dates for the original answers are unverified. Rates rest on the answers that met the benchmark's inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording. Top-three and first-place counts sit inside recommendations rather than adding to them.

Answers can name several companies, so company counts do not sum to distinct answers. Sentiment describes answer wording, not customer satisfaction. Cited pages and disputed claims still need independent checking, and monthly samples differ, so comparisons show what changed, not why.

Our first three priorities

First, resolve the operating-status and authorization questions from current primary sources, since those claims sit closest to a purchase decision and carry the highest recorded severity. Until they are confirmed, no correction request should go out.

Second, strengthen the accuracy and ancestry pages the client already owns, using approved facts and the buyer questions recorded here, so the brand has citable material behind its name. Third, review the most-cited external pages and prepare evidence-backed requests only where a real inaccuracy is confirmed. Together these address the recommendation gap rather than the already-strong mention rate.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

Archived editions

Browse earlier published research snapshots for this article. The latest edition remains at the current URL.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT